phase readout
saveNCT01937468: Trial of Regulatory T-cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease
ACTIVE_NOT_RECRUITINGupdated 2mo ago
community read0 votes
Sponsor: Dana-Farber Cancer Institute. Phase: PHASE1. Conditions: Chronic Graft Versus Host Disease, Chronic GVHD, Complications of Organ Transplant Stem Cells
view source ↗
comments(0)
5-min edit window · permanent after that